<--- Back to Details
First PageDocument Content
Bacteria / Tuberculosis treatment / Rifampicin / Isoniazid / Drug resistance / Streptomycin / Multi-drug-resistant tuberculosis / Tuberculosis / Medicine / Health
Date: 2012-05-02 14:00:37
Bacteria
Tuberculosis treatment
Rifampicin
Isoniazid
Drug resistance
Streptomycin
Multi-drug-resistant tuberculosis
Tuberculosis
Medicine
Health

Drug-Resistant Tuberculosis Cases,

Add to Reading List

Source URL: epi.ncpublichealth.com

Download Document from Source Website

File Size: 133,96 KB

Share Document on Facebook

Similar Documents

Joint Statement on Antimicrobial Resistance Executive Summary Antimicrobial resistance, also known as AMR, is a major public health threat. The estimated burden of deaths from drug resistant infections is calc

DocID: 1uNZ0 - View Document

TACKLING DRUG-RESISTANT INFECTIONS GLOBALLY: FINAL REPORT AND RECOMMENDATIONS THE REVIEW ON ANTIMICROBIAL RESISTANCE

DocID: 1tod4 - View Document

Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding Keith P. Romano1, Akbar Ali1, William E. Royer, and Celia A. Schiffer2 Department of Biochemistry

DocID: 1tlKl - View Document

WHO/TDR TB Strain Bank New diagnostics tests for tuberculosis (TB) suitable for low-income settings are urgently needed. This includes tests for the detection of drug resistance which are of ever increasing importance as

DocID: 1t8wk - View Document

Texas A&M AgriLife ResearchSELECTED ACCOMPLISHMENTS Combating Drug Resistance

DocID: 1slem - View Document